Arteriocyte is now a part of Isto Biologics.

Science

Supported Research

Orthobiologics Grant Program

Investigator-Initiated Research

ISTO’s revolutionary platform technologies are applicable to a broad spectrum of potential clinical uses. By supporting investigator-initiated research through the Orthobiologics Grant Program, we encourage clinicians to explore applications for our bone growth portfolio. Playing an essential role, grant recipients help us understand the versatile ways in which our technologies will help bodies heal.

The first step to becoming a valued collaborator, is to apply. The ISTO Grant Program Committee is ready to review your information and will contact you about how to proceed. As the focus of our grant initiatives change over time, we hope you will contact us to inquire about how your interests coincide with our current research.

Developing breakthrough therapies that improve lives is central to ISTO’s mission.

Ask us about our current research initiatives, or how to apply for a grant.

Contact us

Where We Start, Every Time

“ISTO’s products are based on the strong scientific foundation that we’ve developed, in both creating and designing the treatments as well as establishing the clinical science behind their efficacy.”

Davis Adkisson, ISTO Cofounder and Chief Scientific Officer

To top